How To Spot a 100% Winner
It wasn’t long ago that I highlighted Planet Labs as a stock with the potential to blast off. At the time it was sitting at $1.90 per share.
Fast forward to the present and Planet Labs has soared well above $4 per share and is now posting gains of over 100%.
So what was it that revealed the hallmarks of a stock about to pop? » Read more about: How To Spot a 100% Winner »
Read More
1 Sports Apparel Stock Set To Keep Soaring?
Few investors know that sports apparel giant, Lululemon Athletica, was originally founded as a design studio by day and yoga studio by night. Fast forward to today, and the company is nothing short of a global phenomenon that last week made it into the S&P 500 club.
But what’s on the horizon now for this extraordinary apparel firm?
» Read more about: 1 Sports Apparel Stock Set To Keep Soaring? »
Read More
Market Commentary: What’s Inside Buffett’s Portfolio?
In its latest 13F filing, Berkshire Hathaway bought and sold some stocks that paint a clear picture of what Buffett thinks the future of the economy will look like. Some old favorites he left untouched while others he sold off with abandon. Yet other stocks, he accumulated in spades.
What is Buffett buying and selling now?
» Read more about: Market Commentary: What’s Inside Buffett’s Portfolio? »
Read More
Market Commentary: The Meteoric Rise of Eli Lilly
Did you know that Eli Lilly and other pharmaceutical companies have sold approximately 10.6 million shots of obesity drug doses in the U.S. in a single month? The rise of these injectable weight loss medications is so powerful that it’s causing investors to question the future of even staple food and beverage stocks.
While this aspect alone could secure Eli Lilly as the pharmaceutical golden goose you’ve been looking for there is much more than meets the eye.
» Read more about: Market Commentary: The Meteoric Rise of Eli Lilly »
Read More
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
1 Cash Cow with Massive Upside
CVS Health (NYSE:CVS) share price declined by over 23% over the past twelve months. Hurting shareholders was the recent leadership transition from CEO Karen Lynch to David Joyner, a shift that brought uncertainty to the company’s direction as investors questioned the company’s stability while facing ongoing challenges.
» Read more about: 1 Cash Cow with Massive Upside »
Read MoreThe Spotlight
#1 Most Important Rule That Made Millions
When Mark Minervini won the US Trading Championships, some attributed his victory to luck. As the years went by and he kept winning the narrative changed. Then he decided to enter the competition again, and naysayers told him not to risk his reputation. He went on to win once again, out-trading every other competitor and coming top of the podium in the $1 million+ category.
» Read more about: #1 Most Important Rule That Made Millions »
Read MoreThe Daily
Concentrated Stock Positions: Compounding Versus Risk
Warren Buffett and Charlie Munger used concentrated stock positions to compound wealth. The methods … More
AFP via Getty Images
Charlie’s portfolio was concentrated in very few securities and therefore his record was much more volatile but it was based on the same discount-from-value approach.
» Read more about: Concentrated Stock Positions: Compounding Versus Risk »